About Rajkumari Saxena
Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.
Recent Articles By Rajkumari Saxena
Is Now the Right Time to Invest in Danaos Corporation?
Danaos Corporation (DAC) beat analysts’ estimates on the top and bottom lines in the second quarter of 2024. Factors like leading industry position, strategic arrangements, and solid financial performance are key drivers of the company’s continued growth. So, let’s determine whether Danaos Corporation is an ideal addition to your portfolio. Read more to find out...
Is Upstart a Buy as AI Transforms Lending?
Upstart Holdings (UPST) second-quarter results beat analysts’ expectations. While the company’s long-term outlook appears rosy with continuous technological innovation, it faces challenges with profitability and operational efficiency in the near term. So, should you buy Upstart as AI transform lending? Read more to find out...
3 ETFs for a Balanced Growth and Income Portfolio
Investing in ETFs that hold companies with high income and provide long-term growth have significant potential and can effectively diversify the portfolio. Thus, it could be wise to invest in robust tech equities ETFs Vanguard Growth Index Fund ETF Shares (VUG), Vanguard Dividend Appreciation Index Fund ETF Shares (VIG), and Schwab U.S. Dividend Equity ETF (SCHD) for potential gains. Read more...
Is Ollie’s Bargain Outlet a Retail Stock to Watch?
Ollie’s Bargain (OLLI) reported its financial results for the first quarter of 2024. While the specialty retailer’s long-term outlook appears bright with strategic investment and store network expansion, it faces rigid competition and elevated valuation. So, should you buy or keep the stock on hold? Read more to find out...
3 Gene-Editing Stocks to Buy for Future Health Advances
With ever-expanding operations and rapid technological innovations, the gene-editing industry looks poised for solid long-term growth. Thus, investors could consider solid stocks Eli Lilly (LLY), Sanofi (SNY), and Vertex Pharmaceuticals (VRTX). Continue reading...
3 Biotech ETFs for a Diversified Portfolio
The biotech industry is growing rapidly with solid advancements, and ETFs in this sector can offer great investment opportunities. Thus, it could be wise to invest in top biotech ETFs SPDR S&P Biotech ETF (XBI), VanEck Biotech ETF (BBH), and iShares Biotechnology ETF (IBB) for a diversified portfolio. Read on...
3 Must-Have ETFs for Income Investors
Dividend-paying ETFs are ideal for income investors as they provide regular income through dividends while offering diversification across multiple stocks, reducing risk. Therefore, investors could consider Global X NASDAQ 100 Covered Call ETF (QYLD), Invesco S&P 500 High Dividend Low Volatility ETF (SPHD), and Global X SuperDividend U.S. ETF (DIV) for steady returns. Read more...
3 Defense Stocks to Buy as Geopolitical Tensions Rise
The defense industry is transforming continuously to cater to the evolving needs worldwide with advanced technologies. Amid the escalating geopolitical tensions, quality defense stocks Northrop Grumman (NOC), General Dynamics (GD), and Lockheed Martin (LMT) could be ideal portfolio additions. Continue Reading...
3 Small-Cap Software Stocks with Strong Buy Ratings
The software sector is flourishing with increasing demand, investment, and rapid technological advancements. Hence, investors could consider investing in promising small-cap software stocks Magic Software (MGIC), Cognyte Software (CGNT), and Yalla (YALA). Read more…